Viracta Therapeutics Stock Quote VIRX - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.8567

Bid

0.78

Ask

0.95

Volume

52,615

0.8174 Day's Range 0.91

0.43 52 Week Range 2.38

Market Cap

33.774M

Previous Close

0.909

Open

0.8817

Last Trade

0.86

Last Trade Time

Financial Volume

$ 45,380

VWAP

0.862487

Average Volume (3m)

118,271

Shares Outstanding

39,272,434

Dividend Yield

PE Ratio

-0.66

Earnings Per Share (EPS)

-1.3

Revenue

Net Profit

-51.06M

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.viracta.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Viracta Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRX. The last closing price for Viracta Therapeutics was $0.91. Over the last year, Viracta Therapeutics shares have traded in a share price range of $ 0.43 to $ 2.38.

Viracta Therapeutics currently has 39,272,434 shares outstanding. The market capitalization of Viracta Therapeutics is $33.77 million. Viracta Therapeutics has a price to earnings ratio (PE ratio) of -0.66.

Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma

- Patients in the Nana-val (nanatinostat in combination with valganciclovir) treatment arm achieved clinically meaningful anti-tumor responses with an overall response rate of 50% and a complete...

Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan

SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated...

Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial

Accelerated pace of enrollment supports speed to market strategy Topline results from Stage 1 expected to be presented in the second quarter of 2024 followed by Stage 2 data in the third quarter...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.4433	-34.1	1.3	1.31	0.67	292108	0.8828067	CS
4	-0.1833	-17.625	1.04	1.31	0.67	158953	0.98927372	CS
12	0.3567	71.34	0.5	1.31	0.5	118271	0.88027715	CS
26	0.1567	22.3857142857	0.7	1.31	0.43	143502	0.68281185	CS
52	-0.4433	-34.1	1.3	2.38	0.43	155200	1.1336569	CS
156	-7.1933	-89.3577639752	8.05	13.08	0.43	190956	4.37242359	CS
260	-15.9033	-94.888424821	16.76	18.24	0.43	199645	4.8816382	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TWGTop Wealth Group Holding Ltd	$ 3.73 (101.62%)	36.52M
CSLRComplete Solaria Inc	$ 0.465319 (75.59%)	16.64M
SHOTWSafety Shot Inc	$ 0.48 (60.00%)	6.71k
EGOXNext e GO NV	$ 0.0515 (43.06%)	333.3M
MNDRMobile health Network Solutions	$ 27.2386 (33.72%)	10.35M
YYAIConnexa Sports Technologies Inc	$ 0.8943 (-57.21%)	13.4M
SBFMSunshine Biopharma Inc	$ 1.77 (-46.69%)	11.9M
GTIGraphjet Technology	$ 6.43 (-33.09%)	95.33k
ISPCiSpecimen Inc	$ 0.2883 (-31.52%)	2.86M
BGLCBioNexus Gene Lab Corporation	$ 0.5998 (-29.32%)	735.88k
EGOXNext e GO NV	$ 0.0515 (43.06%)	333.3M
SQQQProShares UltraPro Short QQQ	$ 12.84 (6.38%)	219.91M
AGBAAGBA Group Holding Ltd	$ 1.255 (21.84%)	128.79M
TQQQProShares UltraPro QQQ	$ 49.48 (-6.20%)	125.4M
SINTSiNtx Technologies Inc	$ 0.0414 (3.50%)	109.94M